Conclusion:
The rat animal model cannot heal a 5-mm segmental mandibular defect. Successful healing of 0-, 1-, and 3-mm defects confirms adequate stabilization of bony wounds with internal fixation with 1-mm microplates. The rat segmental mandibular critical size defect provides a clinically relevant testing ground for translatable mandibular tissue engineering efforts.
Facial Plastic and Reconstructive Surgery Turbinate Surgery in Rhinoplasty: Randomized Clinical Trial
Michelle Lavinsky-Wolff, MD (presenter); Humberto L. Camargo Jr, MD; Carolina Barone; Luisi Rabaioli; Sara Petersen; Jose E. L. Dolci, MD; Carisi A. Polanczyk, MD Objective: Evaluate the role of turbinate reduction during rhinoplasty in quality-of-life outcomes and nasal airway crosssectional area.
Method: Adults with nasal obstruction, functional and aesthetics primary rhinoseptoplasty candidates were randomized to rhinoseptoplasty with or without inferior turbinate reduction. Study was conducted from December 2010 through January 2011 at the facial plastic clinic of a tertiary center in Brazil. Changes in Nasal Obstruction Symptom Evaluation (NOSE) and WHOQOL-bref scores and acoustic rhinometry (AR) were assessed.
Results: Fifty were included, mainly Caucasians with moderate/severe allergic rhinitis symptoms. Mean age was 32 ± 12 years. Baseline characteristics were similar between groups. Rhinoseptoplasty improved specific and general quality-oflife scores irrespective of turbinate intervention group (P < .001). There was no difference in relative change of NOSE score (-75% vs -73%; P = .893); WHOQOL-bref score domains (Physical: 7% vs 6% [P = .10]; Psychological: 6% vs 7% [P = .158]; Social: 0% vs 0% [P = .99]; Environment 7% vs 5% [P = .77]), NO-VAS (-88% vs -81%; P = .89), and all AR recordings (P > .05) between turbinate reduction and no turbinate reduction groups, respectively.
Conclusion:
Turbinate reduction during primary rhinoplasty did not improve short-term general and specific quality-of-life outcomes or acoustic rhinometry recordings.
Facial Plastic and Reconstructive Surgery Use of SMAS Flap and Fat Graft: Viability and Effectiveness
Lindsay Goodstein (presenter); Bryan T. Ambro, MD, MS; Robert E. Morales, MD; Rodney J. Taylor, MD, MSPH Objective: 1) Evaluate the effectiveness of the superficial musculoaponeurotic system (SMAS) flap and free fat graft in reconstructing the parotidectomy defect. 2) Evaluate the longterm viability of the free fat graft, including in the setting of postoperative radiation.
Method: A prospective, consecutive analysis of patients undergoing parotidectomy for benign and malignant disease from 2006-2011 was performed at an academic university setting. The main outcome measures were the effectiveness of achieving symmetric volume of the ipsilateral parotid defect, long-term viability of the free fat graft, and presence of Frey's syndrome.
Results: Twenty-four consecutive patients received parotidectomy with SMAS flap and free fat graft from 2006-2011. The average age was 56 (range 16-84). Nineteen patients had benign disease, including pleomorphic adenoma, oncocytoma, and Warthin tumor. Five procedures were done for malignant disease, and, in each instance, postoperative radiation was administered. Satisfactory volumetric symmetry was achieved in all procedures for benign and malignant disease. MRI imaging confirmed graft viability even in the setting of postoperative radiation. There was 1 case of Frey's syndrome and no instances of long-term facial weakness among the patients.
Conclusion:
The SMAS flap and free fat graft are an effective approach to reconstructing the parotidectomy defect with minimal morbidity and complication. This study demonstrates long-term viability of the free fat graft in the setting of postoperative radiation. Reconstruction reduces the rate of Frey's syndrome compared to historic rates following surgery.
